Form 144 - Report of proposed sale of securities:
SEC Accession No. 0002007317-25-000883
Filing Date
2025-08-15
Accepted
2025-08-15 15:21:56
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 4799
  Complete submission text file 0002007317-25-000883.txt   6450
Mailing Address 3115 MERRYFIELD ROW THIRD FLOOR SAN DIEGO CA 92121
Business Address 3115 MERRYFIELD ROW THIRD FLOOR SAN DIEGO CA 92121 (858) 465-6511
Erasca, Inc. (Subject) CIK: 0001761918 (see all company filings)

EIN.: 831217027 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-40602 | Film No.: 251224307
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ERASCA, INC. 3115 MERRYFIELD ROW, SUITE 300 SAN DIEGO CA 92121
Business Address C/O ERASCA, INC. 3115 MERRYFIELD ROW, SUITE 300 SAN DIEGO CA 92121 (858) 465-6511
Erasca Foundation (Reporting) CIK: 0001973524 (see all company filings)

EIN.: 000000000
Type: 144